Our broad, long-term objective is to determine the genetic epidemiology of venous thromboembolism (VTE). Segregation analyses show that VTE is highly heritable. The high prevalence of VTE and its known environmental risk factors suggest that multiple genes of varying effects are involved in determining VTE susceptibility. We hypothesize that (1) there are specific discoverable genes and genotypes that greatly increase the risk of VTE, (2) some genotypes may manifest through VTE risk factor exposure, and (3) there are quantitative trait loci (QTL) that pleiotropically affect both plasma hemostasis-related risk factors and VTE. To address these hypotheses, we will use the resources of the eight Thrombophilia Center Pilot sites and the Centers for Disease Control to identify susceptibility genes in high-risk VTE pedigrees.
Our specific aims are:
Aim 1. To identify and extend high-risk VTE pedigrees, collect demographic and VTE risk factor data and samples for DNA and plasma, and genotype informative individuals within these pedigrees for 500,000 single nucleotide polymorphism-based markers evenly spaced throughout the genome. We will identify at least 75 high-risk VTE pedigrees suitable for linkage studies (at least 3 affected family members and ELOD scores=0.3 or higher);genotyping will be done on ~1200 family members;
Aim 2. To map VTE susceptibility genes by genetic linkage analysis. We will use conventional linkage strategies, but we will also implement the latest methods that incorporate environmental covariates in the analysis;
Aim 3. Using the high-risk VTE pedigrees and genotypes from Aim 1, (a) to determine the joint action of genes on VTE risk and a number of quantitative hemostasis-related phenotypes;and (b) to identify regions containing genes (e.g., QTL) that influence variation in highly-heritable quantitative phenotypes that genetically correlate with VTE using variance components approach for quantitative traits;
and Aim 4. To revise the Mayo Thrombophilia Registry to conform to the Thrombosis/Hemostasis Research Network Registry, and continue data abstraction, prospective outcomes follow-up, and Network Registry data entry for Mayo Thrombophilia Center patients. Implications: Through such efforts, the Network will facilitate the development of a family-based gene-discovery research resource that will be positioned to characterize genetic risk of VTE and to conduct future translational studies, including interventions targeted to high risk groups.

Agency
National Institute of Health (NIH)
Institute
Centers for Disease Control and Prevention (NCBDD)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01DD000235-04
Application #
7883311
Study Section
Special Emphasis Panel (ZCD1-CJM (02))
Program Officer
Taylor, Marcia
Project Start
2007-07-15
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
4
Fiscal Year
2010
Total Cost
$200,000
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Faiz, Ambarina S; Khan, Imran; Beckman, Michele G et al. (2015) Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thromb Res 136:535-41
Lewis, Deborah A; Suchindran, Sunil; Beckman, Michele G et al. (2015) Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb Res 135:659-65
Atkinson, Elizabeth J; Eckel-Passow, Jeanette E; Wang, Alice et al. (2015) The association of copy number variation and percent mammographic density. BMC Res Notes 8:297
Attaya, Hosam; Shah, Nilay D; Wysokinski, Waldemar E et al. (2013) Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Int J Cardiol 168:5311-5
Tang, Weihong; Teichert, Martina; Chasman, Daniel I et al. (2013) A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol 37:512-521
Attaya, Hosam; Wysokinski, Waldemar E; Bower, Thomas et al. (2013) Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients. J Thromb Thrombolysis 35:100-6
Heit, J A; Armasu, S M; Asmann, Y W et al. (2012) A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost 10:1521-31
Tafur, A J; Wysokinski, W E; McBane, R D et al. (2012) Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients. Ann Oncol 23:1998-2005
Tafur, A J; McBane 2nd, R; Wysokinski, W E et al. (2012) Predictors of major bleeding in peri-procedural anticoagulation management. J Thromb Haemost 10:261-7
Heit, John A (2012) Predicting the risk of venous thromboembolism recurrence. Am J Hematol 87 Suppl 1:S63-7

Showing the most recent 10 out of 12 publications